98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hrthm.2020.03.017 | DOI Listing |
Lipids Health Dis
December 2022
Department of Cardiology, HHCH, Hefei, Anhui, China.
Background: Little is known about the link between the monocyte to high-density lipoprotein cholesterol ratio (MHR) and frequent premature ventricular complexes (PVCs). This investigation aimed to evaluate the link between the MHR and frequent PVCs in patients, as well as their outcomes, using the axis, burden, coupling interval-ventricular tachycardia (ABC-VT) risk score (ARS).
Methods: Two hundred patients with frequent PVCs and 70 controls were retrospectively enrolled, and their general data were gathered.
Circ Arrhythm Electrophysiol
November 2021
Heart Rhythm Services, Division of Cardiology, University of British Columbia, Canada (M.J.T., F.H., J.G.A., N.M.H., M.W.D.).
Pacing Clin Electrophysiol
August 2021
Arrhythmology Department, IRCCS San Raffaele Hospital, Milan, Italy.
Premature ventricular complexes (PVCs) are increasingly recognized, as the use of ECG wearables becomes more widespread. In particular, PVCs arising from both the right ventricular outflow tract (RVOT) and left ventricular outflow tract (LVOT) comprise the majority of these arrhythmias and form a significant component of an electrophysiology practice. A keen understanding of the correlative anatomy of the outflow tracts, in addition to recognizing key ECG indices illustrating PVC sites of origin, are fundamental in preparing for a successful ablation.
View Article and Find Full Text PDFHeart Rhythm
July 2020
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Heart Rhythm
July 2020
Division of Cardiology, University of California San Francisco, San Francisco, California. Electronic address:
Background: No independently validated score currently exists for risk stratification of patients with frequent premature ventricular complexes (PVCs).
Objectives: The purpose of this study was to develop a risk score to predict adverse events in patients with frequent PVCs.
Methods: We analyzed consecutive patients between 2012 and 2017 undergoing 14-day continuous monitoring with frequent PVCs (>5%) and concurrent echocardiography.